期刊文献+

血液透析患者自体动静脉内瘘血栓形成的危险因素分析 被引量:4

Risk factors analysis for hemodialysis with autogenous artoriovenous fistuia thrombosis
原文传递
导出
摘要 目的 探讨影响血液透析患者自体动静脉内瘘早期血栓形成的危险因素为临床干预提供参考依据.方法 观察慢性血液透析患者104例,在首次使用自体动静脉内瘘后3个月内是否发生血栓形成.对患者年龄、性别、基础疾病是否为糖尿病、平均血压水平、发生血栓时单次超滤量、发生血栓时的血肌酐、尿酸、尿素、血白蛋白、血红蛋白、血小板、甲状旁腺素等指标量化后行多因素非条件logistic回归分析.结果 21例(20.1%)患者在血液透析后3个月内出现动静脉内瘘血栓形成,基础疾病为糖尿病、血肌酐、甲状旁腺素水平、血红蛋白为发生血栓形成的危险因素.血压、尿酸是动静脉内瘘形成的保护因素.结论 本研究进一步揭示基础疾病为糖尿病、血红蛋白、血液透析不充分、甲状旁腺激素异常升高为血液透析患者早期形成动静脉内瘘血栓的危险因素. Objectives The aim of this study is to discover the risk factors predicting early thrombosis and use of autogenous arteriovenous fistulae for hemodialysis.Methods January 2011 to December 2012,104 patients undergoing first time AVF creation were enrolled in our retrospective study.We analyzed age,sex,based diseases,blood pressure,ultra-filtration volume,urea,creatinine,uric acid,blood albumin,hemoglobin,platelet,such as parathyroid hormonewith Multi-factor Unconditioned Logistic Analysis.Results 21 patients (20.1%) developed thrombus in three months after first blood dialysis.basic diseases as diabetes,creatinine,parathyroid hormone,hemoglobin as risk factors.The protecting factors include blood pressure,uric acid for patient of thrombosis.Conclusions Early thrombosis of AVF occurs mainly among diabetic patients,hemoglobin,inadequate hemodialysis,high parathyroid hormone.
出处 《国际泌尿系统杂志》 2013年第5期648-650,共3页 International Journal of Urology and Nephrology
关键词 肾透析 动静脉内瘘 血栓形成 危险因素 Renal Dialysis Arteriovenous Fistula Thrombosis Risk Factors
  • 相关文献

参考文献9

二级参考文献12

  • 1王玉柱.血液透析自体动静脉内瘘狭窄相关因素分析[J].中国误诊学杂志,2005,5(2):213-215. 被引量:49
  • 2戎殳,李惠民,叶朝阳,严丙曰,肖湘生,梅长林.CO_2血管造影在血液透析血管通路功能评价中的初步应用[J].中国中西医结合肾病杂志,2005,6(9):520-522. 被引量:10
  • 3Ghislaine Medkouri, Rachid Aghai, Aabdelkbir Anabi, et al. Analysis of vascular access in hemodialysis patients: a report from a dialysis unit in casablanca[J]. Saudi J Kindney Dis Transplant, 2006,17:516-520.
  • 4Greg A. Knoll, Philip S. Wells, Darlene Young, et al. Thrombophilia and the risk for hemodialysis vascular access thrombosis[J]. J Am Soc Nephrol, 2005,16:1108-1114.
  • 5Allon M, Robbin ML. Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions[J]. Kindney Int, 2002,62:1109- 1124.
  • 6Edwin Wijnen, Niis Planken, Xavier Keuter, et al. Impact of a quality improvement programme based on vascular access flow monitoring on costs, access occlusion and access failure[J]. Nephrol Dia Transplant, 2006,21:3514-3519.
  • 7Pietro Ravani, Lawrence M. Spergel, Arif Asif, et al. Clinical epidemiology of arteriovenous fistula in 2007 [J]. J Nephrol, 2007,20:141- 149.
  • 8Pasceri V, Chang J, Willerson JT, Yeh ET. Modulation of Creactive protein mediated monoeyte chemoattractant protein-1 induction in human endothelial cells by anti-ath eroselerosis drugs[J]. Circulation, 2001, 103:2531- 2534.
  • 9Costa E, Rocha S, Rocha Pereira P, et al. Cross-talk between inflammation, coagulation fibrinolysis and vascular access in hemodialysis patients[J]. J Vasc Access, 2008,9:248 -253.
  • 10Bagolan P,SPagnoli A,CiPrandi g,et al.A ten year experience of Brescia-Cimino arterioveneous fistula in children:technical evolution and refinements.J Vasc Surg,1998,27(4):640-644.

共引文献40

同被引文献51

引证文献4

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部